Pulmonary Aspergillosis in a Patient with Chronic Granulomatous Disease: Confirmation by Polymerase Chain Reaction and Serological Tests, and Successful Treatment with Voriconazole

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 22, Issue 11, 2003, Pages 681-685

  Sambatakou, H ^a,c   Guiver, M ^b   Denning, D ^a  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

^b WITHINGTON HOSPITAL   (United Kingdom)

^c G GENNIMATAS GENERAL HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; COTRIMOXAZOLE; FUNGAL DNA; VORICONAZOLE;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ASPERGILLUS; BLOOD ANALYSIS; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG EFFICACY; FUNGAL DETECTION; HEMODYNAMICS; HUMAN; LUNG ASPERGILLOSIS; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPUTUM ANALYSIS; THORAX RADIOGRAPHY;

ADULT; ANTIFUNGAL AGENTS; ASPERGILLOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FUNGEMIA; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; LUNG DISEASES, FUNGAL; MALE; POLYMERASE CHAIN REACTION; PYRIMIDINES; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; TREATMENT OUTCOME; TRIAZOLES;

EID: 0344513395     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-003-1007-2     Document Type: Article

References (36)

1. Dinauer M, Orkin S, Brown R, Jesaitis A, Parkos C (1987) The glycoprotein encoded by the X-linked chronic granulomatous disease locus in a component of the neutrophil cytochrome b complex. Nature 327:717-720
2. Jirapongsananuruk O, Niemela JE, Malech HL, Fleisher TA (2002) CYBB mutation analysis in X-linked chronic granulomatous disease. Clin Immunol 104:73-76
3. Mouy R, Fischer A, Vilmer E, Seger R, Griscelli C (1989) Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr 114:555-560
4. Finn A, Hadzic N, Morgan G, Strobel S, Levinsky RJ (1990) Prognosis of chronic granulomatous disease. Arch Dis Child 65:942-945
5. Loeffler J, Schmidt K, Hebart H, Schumacher U, Einsele H (2002) Automated extraction of genomic DNA from medically important yeast species and filamentous fungi by using the MagNA Pure LC system. J Clin Microbiol 40:2240-2243
6. Kami M, Fukui T, Ogawa S, Kazuyama Y, Machida U, Tanaka Y, Kanda Y, Kashima T, Yamazaki Y, Hamaki T, Mori S, Akiyama H, Mutou Y, Sakamaki H, Osumi K, Kimura S, Hirai H (2001) Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis. Clin Infect Dis 33:1504-1512
7. Liese J, Kloos S, Jendrossek V, Petropoulou T (2000) Long-term follow-up and outcome of 39 patients with chronic granulomatous disease. J Pediatr 137:687-693
8. Casson DH, Riordan FA, Ladusens EJ (1996) Aspergillus endocarditis in chronic granulomatous disease. Acta Paediatr 85:758-759
9. Gupta PK, Mahapatra AK, Gaind R, Bhandari S, Musa MM, Lad SD (2001). Aspergillus spinal epidural abscess. Pediatr Neurosurg 35:18-23
10. Margolis DM, Melnick DA, Alling DW, Gallin JI (1990) Trimethoprim- sulfamethoxazole prophylaxis in the management of chronic granulomatous disease. J Infect Dis 162:723-726
11. Progrebniak H, Gallin J, Malech H, Baker A, Moskaluk C, Travis W, Pass H (1993) Surgical management of pulmonary infections in chronic granulomatous disease of childhood. Ann Thorac Surg 55:844-849
12. Roilides E, Sigler L, Bibashi E, Katsifa H, Flaris N, Panteliadis C (1999) Disseminated infection due to Chrysosporium zonatum in a patient with chronic granulomatous disease and review of non-Aspergillus fungal infections in patients with this disease. J Clin Microbiol 37:18-25
13. Jabado N, Casanova JL, Haddad E, Dulieu F, Fournet JC, Dupont B, Fischer A, Hennequin C, Blanche S (1998) Invasive pulmonary infection due to Scedosporium apiosperum in two children with chronic granulomatous disease. Clin Infect Dis 27:1437-1441
14. Mouy R, Veber F, Blanche S, Donadieu J, Brauner R, Levron JC, Griscelli C, Fischer A (1994) Long-term itraconazole prophylaxis against Aspergillus infections in thirty-two patients with chronic granulomatous disease. J Pediatr 125:998-1003
15. Casale TB, Macher AM, Fauci AS (1984) Concomitant pulmonary aspergillosis and nocardiosis in a patient with chronic granulomatous disease of childhood. South Med J 77:274-275
16. Olive D, Burioti D, Brocard O, Griscelli C (1979) Pulmonary aspergillosis and chronic septic granulomatosis. Arch Fr Pediatr 36:298-302
17. Abati A, Cajigas A, Holland SM, Solomon D (1996) Chronic granulomatous disease of childhood: respiratory cytology. Diagn Cytopathol 15:98-102
18. Dorman SE, Guide SV, Conville PS, DeCarlo ES, Malech HL, Gallin JI, Witebsky FG, Holland SM (2002) Nocardia infection in chronic granulomatous disease. Clin Infect Dis 35:390-394
19. Roback SA, Weintraub WH, Good RA et al. (1971) Chronic granulomatous disease of childhood: surgical considerations. J Pediatr Surg 6:601-611
20. Bretagne S, Costa MJ, Bart-Delabesse E, Dhedin N, Rieux C, Cordonnier C (1998) Comparison of serum galactomannan antigen detection and competitive polymerase chain reaction for diagnosing invasive aspergillosis. Clin Infect Dis 26:1407-1412
21. Verweij PE, Latge JP, Rijs AJMM, Melchers WJG, De Pauw BE, Hoogkamp-Korstanje JAA, Meis JFGM (1995) Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for haematological malignancies. J Clin Microbiol 33:3150-3153
22. Ascioglou S, Rex JH, de Pauw B, Bennet JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34:7-14
23. Tsuge I, Makimura K, Natsume J, Kubota T, Hasegawa S, Kawabe T, Nakashima S, Aso K, Negoro T, Watanabe K (1998) Successful polymerase chain reaction-based diagnosis of fungal meningitis in a patient with chronic granulomatous disease. Acta Paediatr Jpn 40:356-359
24. Maertens J, Verhaegen J, Demuynck H, Brock P, Verhoef G, Vandenberghe P, Van Elderle J, Verbist L, Boogaerts M (1999) Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for haematological patients at risk for invasive aspergillosis. J Clin Microbiol 37:3223-3228
25. Verweij PE, Weemaes CM, Curfs Jo HAJ, Bretagne S, Meis JFGM (2000) Failure to detect circulating Aspergillus markers in a patient with chronic granulomatous disease and invasive aspergillosis. J Clin Microbiol 38:3900-3901
26. Eppinger TM, Greenberger PA, White DA, Brown AE, Cunningham-Rundles C (1999) Sensitization to Aspergillus species in the congenital neutrophil disorders chronic granulomatous disease and hyper-IgE syndrome. J Allergy Clin Immunol 104:1265-1272
27. Saulsbury FT (2001) Successful treatment of Aspergillus brain abscess with itraconazole and interferon-gamma in a patient with chronic granulomatous disease. Clin Infect Dis 32:137-139
28. Spencer DA, John P, Ferryman SR, Weller PH, Darbyshire P (1994) Successful treatment of invasive pulmonary aspergillosis in chronic granulomatous disease with orally administered itraconazole suspension. Am J Respir Crit Care Med 149:239-241
29. Kloss S, Schuter A, Schroten H, Lamprecht J, Wahn V (1991) Control of proven pulmonary and suspected CNS Aspergillus infection with itraconazole in a patient with chronic granulomatous disease. Eur J Pediatr 150:483-485
30. Bernhisel-Broadbent J, Camargo EE, Jaffe HS, Lederman HM (1991) Recombinant human interferon-gamma as adjunct therapy for Aspergillus infection in a patient with chronic granulomatous disease. J Infect Dis 163:908-911
31. Touza Rey F, Martinez Vasquez C, Alonso Alonso J, Mendez Pineiro MJ, Rubianes Gonzalez M, Crespo Casal M (2000) The clinical response to interferon-gamma in a patient with chronic granulomatous disease and brain abscesses due to Aspergillus fumigatus. Ann Intern Med 17:86-87
32. Denning WD, Ribaud P, Milpied N, Caillot D, Herbrecht R, Thiel E, Haas A, Ruhnke M, Lode H (2002) Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis 34:563-571
33. Herbrecht R, Denning WD, Patterson FT, Bennett EJ, Greene ER, Oestmann WJ, Kern VW, Marr K, Ribaud P, Lortholary O et al. (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347:408-415
34. Walsh TJ, Lutsar I, Driscoll T, Dupont B, Roden M, Ghahramani P, Hodges M, Groll AH, Perfect JR (2002) Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Pediatr Infect Dis J 21:240-248
35. Hek LG van't, Verweij PE, Weemaes CM, Dalen R van, Yntema JB, Meis JF (1998) Successful treatment with voriconazole of invasive aspergillosis in chronic granulomatous disease. Am J Respir Crit Care Med 157:1694-1696
36. Hilbert G, Gruson D, Vargas F, Valentino R, Gbikpi-Benissan G, Dupon M, Reiffers J, Cardinaud J (2001) Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 344:481-487